Director or Senior Director, Investor Relations and Corporate Communications

Lyell Immunopharma · USA

Apply on the employer’s site Open in Atlas

About this role

Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However, these profound results have not yet been achieved in patients with solid tumors, representing approximately 90% of all cancers. And for patients with hematologic malignancies…

Excerpt only. The full posting is on the employer’s careers site.

More jobs at Lyell Immunopharma

• Director, Medical Writing
  Lyell Immunopharma · USA · $220,000 – $240,000 per year
• Associate Director, FP&A
  Lyell Immunopharma · USA · $170,000 – $210,000 per year
• Associate Director, Clinical Development Program Management
  Lyell Immunopharma · South San Francisco, California, United States · $200,000 – $240,000 per year
• Associate Director, Medical Affairs Operations
  Lyell Immunopharma · USA · $180,000 – $230,000 per year